Healthcare Global Enterprises
Healthcare Global Enterprises Share Price Chart
Healthcare Global Enterprises last traded at ₹585.15 (2026-10-13). Over the past month the stock moved -17.0%, three months the stock moved -10.8%, year the stock moved -9.1%. Its closing range over 52 weeks is ₹527.70 – ₹754.93, with the latest close 22.5% below the high.
Closing prices up to 2026-10-13.
About Healthcare Global Enterprises
Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]
Service Offering The Company is a provider of specialty healthcare focused on cancer and fertility. Under the “HCG” brand, it operates the largest cancer care network in India in terms of the total number of private cancer treatment centers licensed by the AERB. It also provides fertility treatment under our “Milann” brand. [1]
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Healthcare Global Enterprises reported sales of ₹695.00 crore (+13.4%) and net profit of ₹16.00 crore (+166.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 695.00 | 122.00 | 18.00 | 16.00 | 0.92 |
| Mar 2026 | 652.00 | 125.00 | 19.00 | 4.00 | 0.15 |
| Dec 2025 | 633.00 | 110.00 | 17.00 | -8.00 | -0.63 |
| Sep 2025 | 647.00 | 123.00 | 19.00 | 21.00 | 1.09 |
| Jun 2025 | 613.00 | 108.00 | 18.00 | 6.00 | 0.32 |
| Mar 2025 | 585.00 | 106.00 | 18.00 | 7.00 | 0.50 |
| Dec 2024 | 559.00 | 88.00 | 16.00 | 8.00 | 0.47 |
| Sep 2024 | 554.00 | 102.00 | 18.00 | 21.00 | 1.22 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +13.8% | +18.9% | +18.2% | +16.5% | +16.8% | +13.2% | +11.5% | +13.4% |
| Operating profit growth | +20.0% | +11.4% | +15.2% | +18.7% | +20.6% | +25.0% | +17.9% | +13.0% |
| Net profit growth | +90.9% | +166.7% | -69.6% | -57.1% | +0.0% | -200.0% | -42.9% | +166.7% |
| EPS growth | +32.6% | +20.5% | -65.3% | -61.0% | -10.7% | -234.0% | -70.0% | +187.5% |
| OPM % | 18.0% | 16.0% | 18.0% | 18.0% | 19.0% | 17.0% | 19.0% | 18.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Healthcare Global Enterprises reported sales of ₹2,545.00 crore (+14.5%) and net profit of ₹23.00 crore (-53.1%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2,545 | 466.00 | 18.00 | 23.00 | 0.92 |
| Mar 2025 | 2,223 | 387.00 | 17.00 | 49.00 | 3.19 |
| Mar 2024 | 1,908 | 327.00 | 17.00 | 41.00 | 3.46 |
| Mar 2023 | 1,691 | 297.00 | 18.00 | 18.00 | 2.11 |
| Mar 2022 | 1,395 | 234.00 | 17.00 | 39.00 | 3.87 |
| Mar 2021 | 1,009 | 122.00 | 12.00 | -221.00 | -15.43 |
| Mar 2020 | 1,092 | 157.00 | 14.00 | -125.00 | -12.03 |
| Mar 2019 | 976.00 | 112.00 | 11.00 | -31.00 | -2.82 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +17.7% | +11.9% | -7.6% | +38.3% | +21.2% | +12.8% | +16.5% | +14.5% |
| Operating profit growth | -3.4% | +40.2% | -22.3% | +91.8% | +26.9% | +10.1% | +18.3% | +20.4% |
| Net profit growth | -282.4% | – | – | – | -53.8% | +127.8% | +19.5% | -53.1% |
| EPS growth | -219.5% | – | – | – | -45.5% | +64.0% | -7.8% | -71.2% |
| OPM % | 11.0% | 14.0% | 12.0% | 17.0% | 18.0% | 17.0% | 17.0% | 18.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Healthcare Global Enterprises.
Get Free AI Stock Analysis FREE →Latest News
-
HCG files FY26 BRSR report with exchanges detailing ESG metrics - scanx.trade
-
HCG CEO Manish Mattoo sees margin expansion, acquisitions driving next leg of growth - Moneycontrol.com
-
Buy HealthCare Global Enterprises; target of Rs 800: ICICI Securities - Moneycontrol.com
-
HealthCare Global Enterprises Concall Update: Margin Targets and Expansion Plans - scanx.trade
-
Healthcare Global Enterprises gains on receiving approval to make further investment of Rs 16 crore in HCG Rajkot
-
Healthcare Global Enterprises to make further investment of Rs 16 crore in HCG Rajkot
-
Healthcare Global Enterprises surges as its arm inks pact to acquire 26% stake in EVRE
-
Healthcare Global Enterprises signs SPA to divest entire stake in BACC Health Care
-
Healthcare Global Enterprises moves up on launching new cancer hospital in North Bengaluru
-
Healthcare Global Enterprises launches new cancer hospital in North Bengaluru
Frequently Asked Questions
What is the share price of Healthcare Global Enterprises today?
Healthcare Global Enterprises shares were last quoted at ₹585.15 (-0.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Healthcare Global Enterprises?
Healthcare Global Enterprises has a price-to-earnings (P/E) ratio of 458.82 and a price-to-book (P/B) ratio of 7.78. The industry P/E is 101.02.
What is the 52-week high and low of Healthcare Global Enterprises?
The 52-week high of Healthcare Global Enterprises is ₹799.36 and the 52-week low is ₹513.40.
What is the market cap of Healthcare Global Enterprises?
The market capitalisation of Healthcare Global Enterprises is about ₹10,481.01 crore.
How did Healthcare Global Enterprises perform in its latest quarterly results?
In the latest quarter (Jun 2026), Healthcare Global Enterprises reported sales of ₹695.00 crore (+13.4%) and net profit of ₹16.00 crore (+166.7%), compared with the same quarter last year.
Is Healthcare Global Enterprises a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Healthcare Global Enterprises has a 3-year ROE of 4.00%, 3-year profit growth of -1.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Healthcare Global Enterprises?
Promoters hold about 64.21% of Healthcare Global Enterprises.
Which sector does Healthcare Global Enterprises belong to?
Healthcare Global Enterprises belongs to the Hospital & Healthcare Services sector.
Other Hospital & Healthcare Services stocks
- Apollo Hospitals Enterprises
- Max Healthcare Institute
- Manipal Health Enterprises
- Aster DM Quality Care
- Fortis Healthcare
- Global Health
- Narayana Hrudayalaya
- Krishna Institute of Medical Sciences
All Hospital & Healthcare Services stocks · Browse all stocks A–Z